Haleon reports executive share transactions

Published 13/05/2025, 18:04
Haleon reports executive share transactions

Haleon plc (LSE/NYSE:HLN), a global consumer health company, disclosed today that Adrian Morris, its General Counsel and Person Discharging Managerial Responsibilities (PDMR), acquired shares under the company’s Share Reward Plan. On Monday, Morris purchased 31 ordinary shares at £4.03 each and was awarded an additional 31 matching shares at no cost, totaling 62 shares. Tamara Rogers, Chief Marketing Officer and PDMR, participated in the same transaction structure and on the same date.

These transactions are part of Haleon’s incentive plan, which aims to align the interests of the company’s executives with those of its shareholders. The purchases and corresponding awards were conducted on the London Stock Exchange (LON:LSEG).

The notification of these transactions comes in accordance with the UK Market Abuse Regulation, which mandates public disclosure of transactions by PDMRs.

Haleon, known for brands like Advil, Centrum, and Sensodyne, specializes in products across Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.

The information provided is based on a press release statement and is intended for informational purposes only, reflecting the company’s adherence to regulatory requirements and its commitment to transparency in executive dealings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.